Home · Compare
Mayukh Sukhatme vs Michael S. Weiss
💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Mayukh Sukhatme earned $236.0M (1490%) more than Michael S. Weiss in their most recent fiscal years on record.
CompanyRoivant SciencesTG Therapeutics
TitlePresident and Chief Investment OfficerExecutive Officer
IndustryHealthcareHealthcare
Fiscal YearFY2024FY2023
Total Pay$251.9M$15.8M
Base Salary$550,000$875,000
Stock Awards$170.2M$13.9M
Bonus$81.1M—
Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy